Graham Capital Management L.P. Takes Position in Henry Schein, Inc. (NASDAQ:HSIC)

Graham Capital Management L.P. purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 14,663 shares of the company's stock, valued at approximately $1,015,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Ethic Inc. raised its position in shares of Henry Schein by 13.1% in the fourth quarter. Ethic Inc. now owns 13,423 shares of the company's stock valued at $929,000 after purchasing an additional 1,552 shares during the period. D. E. Shaw & Co. Inc. raised its position in shares of Henry Schein by 45.9% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 238,626 shares of the company's stock valued at $16,513,000 after purchasing an additional 75,118 shares during the period. Deutsche Bank AG raised its position in shares of Henry Schein by 21.0% in the fourth quarter. Deutsche Bank AG now owns 647,022 shares of the company's stock valued at $44,774,000 after purchasing an additional 112,408 shares during the period. Baird Financial Group Inc. raised its position in shares of Henry Schein by 36.3% in the fourth quarter. Baird Financial Group Inc. now owns 5,438 shares of the company's stock valued at $376,000 after purchasing an additional 1,447 shares during the period. Finally, Balyasny Asset Management L.P. bought a new stake in shares of Henry Schein in the fourth quarter valued at approximately $5,565,000. Institutional investors own 96.62% of the company's stock.

Insiders Place Their Bets

In other news, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. UBS Group lowered their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Jefferies Financial Group upped their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. StockNews.com lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Piper Sandler decreased their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Finally, Wells Fargo & Company decreased their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $79.30.

Henry Schein Stock Up 0.1%

Shares of NASDAQ:HSIC opened at $70.54 on Wednesday. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The firm has a fifty day moving average of $67.52 and a 200 day moving average of $71.45. The firm has a market capitalization of $8.59 billion, a PE ratio of 29.03, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same period in the previous year, the business earned $1.10 earnings per share. The firm's quarterly revenue was down .1% compared to the same quarter last year. As a group, research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.